Prozac Articles
Stock Commentary New York
28 October 1999
Eli Lilly suffers from poor Prozac sales
22 October 1999
FDA backs Eli Lilly's Prozac for use in geriatric depression
12 October 1999
Pfizer gains FDA committee OK for Zoloft in PTSD
12 October 1999
Stock Commentary New York
30 September 1999
Stock Commentary New York
2 September 1999
World's top-selling drugs; 2002 forecasts
13 August 1999
P&U's reboxetine is "approvable" in USA
3 August 1999
Eli Lilly: Correction
15 July 1999
Generic approvals for Norton in UK
1 July 1999
Zyprexa efficacy in bipolar disorder
24 June 1999
Beyond Prozac : Lilly outlines future
14 June 1999
Stock Commentary New York
10 June 1999
US DTC ad awareness, men vs women
2 June 1999
Reboxetine tops Prozac in head-to-head study
28 May 1999
US DTC Rx ad spend hit $1.3 billion in 1998
25 May 1999
Third-party payers lead Rx payments
5 May 1999
Stock Commentary New York
22 April 1999
HMO "not dropping Prozac or Prilosec"
21 April 1999
Sepracor falls on Xopenox rebuke
21 April 1999
Depression will boost US pharma sales
20 April 1999
Stock Commentary New York
29 March 1999
Analysts view FTC price-fixing probe
12 March 1999
Dramatic growth in antidepressant use in Australia
24 February 1999
Sepracor losses grow but market keeps faith
22 February 1999
Lilly paying $4 million to settle Prozac case
27 January 1999
Lilly's Prozac case with Barr Labs begins
25 January 1999
Sepracor tops analysts' biotech stocks
20 January 1999
SSRIs set to boom in Euro depression mkt
15 January 1999
Osteoporosis Drug Evista Halves Breast Cancer Risk
16 December 1998
Osteoporosis Drug Evista Halves Breast Cancer Risk
14 December 1998
Stock Commentary New York
10 December 1998
Lilly Licenses Prozac Successor
8 December 1998
Advances In CNS Therapeutics Reviewed By Lehman Analysts
30 November 1998
Analysts Taking Stock Of Pharma Firms, Prospects Still Good
26 November 1998
Lilly Focusing On Core Business, Prozac Case Looms
20 November 1998
Eli Lilly's Prozac Effective In Panic Disorder
19 November 1998
CNS Patient Knowledge "Driven By Internet And DTC"
10 November 1998
Effexor Shows Rapid Onset Of Efficacy Versus Prozac
6 November 1998
Healthy Third-Quarter Growth For US Drug Majors
22 October 1998
FDA Rejection Of Lilly's Zyprexa A Surprise For Analysts
20 October 1998
Sepracor Phase I clinical trials of (R)-fluoxetine start
15 October 1998
Prozac Ads Shown On Cable TV
25 September 1998
Phentermine To Blame for Fen-Phen Side Effects?
1 September 1998
Healthy Second-Quarter Growth For US Drug Firms
29 July 1998
Remeron Outperforms SSRIs In Trials
22 July 1998
US Psychiatric Drug "Price-Gouging:" Report
17 July 1998
US DTC Ad Spending "To Grow 50% This Year"
13 July 1998
Lilly Planning To Make Prozac In China
25 June 1998
UK Pharma Leaders Outline Strategy
22 June 1998
Pharma "Becoming A Less Easy Revenue Source"
1 June 1998
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
US Quarterly Financial Results Round-Up
23 April 1998
Sepracor Granted "New Fluoxetine" Patent
23 April 1998
CNS Generics "Battle Imminent"
21 April 1998
Unprecedented Take-Off For Pfizer's Viagra
21 April 1998
Rx Drug Sales In USA Grew 12.6% Last Year
6 April 1998
Stock Commentary New York
26 March 1998
Stock Commentary New York
12 February 1998
Expanded Warnings For J&J's Hismanal
11 February 1998
Trend For 1997 Strong Sales Continues In USA
5 February 1998
Eli Lilly: Prozac Case
15 January 1998
NeuroSearch Sees Successful Product Year
27 November 1997
3rd-Qtr Rx Drug Prices Up 2.9%, Generics Fall 6.4%
25 November 1997
Lilly Wins Prozac Patent Dispute
13 November 1997
Drug Promo Meetings "Up 61% Since 1995"
27 October 1997
New York Stock Comment
23 October 1997
US 3rd Quarter Results Show Strong Growth
22 October 1997
American Home Doesn't Fear Diet Pill Law Suits
6 October 1997
GW's Zantac Knocked Off Top US Rx Drug Spot
4 September 1997
Wyeth To Begin Redux Neurotoxicity Study
4 September 1997
Clinton Plans New Rules On Child Drug Safety
19 August 1997
Smaller US Firms' Losses Grow Due To R&D Costs
31 July 1997
First Launch For P&U's Edronax
31 July 1997
Zoloft Becomes 2nd SSRI Cleared For Panic
23 July 1997
US Rx Drug Sales In Jan-April
11 July 1997
Imminent UK Launch Of P&U's Edronax
3 July 1997
Lilly Takes $2.4 Billion Charge For PCS
26 June 1997
Lilly To Write Down The Value OF PCS?
12 June 1997
Prozac Effective In Anorexia?
26 May 1997
High SSRI Link To Sexual Dysfunction
5 May 1997
Generic Prozac
5 May 1997
Strong Dollar Impact On Eli Lilly
5 May 1997
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
